Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06568198 · ClinicalTrials.gov registry record · Phase 2
Modulation Effect of tACS on Chronic Low Back Pain
A Phase 2 study of Chronic Low Back Pain, sponsored by Massachusetts General Hospital.
- Recruiting
- Registry status
- Phase 2
- Development phase
- 80
- Enrollment target
- 1
- Study location
NCT06568198 is a Phase 2 study of Chronic Low Back Pain that is actively recruiting participants, run by Massachusetts General Hospital. The registered enrollment target is 80 participants, below the 591-participant average among 71 other Chronic Low Back Pain trials with a reported enrollment target (86% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06568198, a Phase 2 study of Chronic Low Back Pain, is actively recruiting participants, sponsored by Massachusetts General Hospital.
- RECRUITING
- Registry status
- Phase 2
- Development phase
- 80 participants
- Enrollment target
- 1
- Study location
Study Summary
Investigating the modulation effect of tACS
Conditions Studied
Interventions
- DEVICE Sham tACS
- DEVICE Real tACS
Study Locations (1)
Massachusetts
- Massachusetts General Hospital - Charlestown
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2025-08-25 |
| Est. Completion | 2028-02-28 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06568198
The ClinicalTrials.gov registry entry for NCT06568198 describes a study currently listed as recruiting, categorized as Phase 2. The registered enrollment target is 80 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 591-participant average among 71 other Chronic Low Back Pain trials with a reported enrollment target (86% lower). The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Chronic Low Back Pain appearing as the primary indexed condition, and to 2 interventions - of which Sham tACS is the first listed.
NCT06568198 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.
Frequently Asked Questions
What is clinical trial NCT06568198 about?
NCT06568198 is a clinical study titled "Modulation Effect of tACS on Chronic Low Back Pain". Investigating the modulation effect of tACS
What is the current status of trial NCT06568198?
This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 80 participants. The study started on 2025-08-25. Estimated completion is 2028-02-28.
What conditions does trial NCT06568198 study?
This clinical trial studies the following conditions: Chronic Low Back Pain.
What interventions are being tested in trial NCT06568198?
The interventions under investigation include: Sham tACS (DEVICE), Real tACS (DEVICE).
Who is sponsoring clinical trial NCT06568198?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06568198 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Chronic Low Back Pain
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Ketamine-assisted Integrative Treatment for Veterans With Chronic Low Back Pain and Comorbid Depression
RECRUITING · Phase 2
-
A Master Protocol Study (LY900028) of Multiple Intervention-Specific-Appendices (ISAs) in Participants With Chronic Pain
RECRUITING · Phase 2
-
Project 1 Aim 2, Adaptations of the Brain in Chronic Pain With Opioid Exposure
ACTIVE NOT RECRUITING · Phase 2
-
Low-Dose Naltrexone and Acetaminophen Combination in the Treatment of Chronic Low Back Pain (ANODYNE-4)
COMPLETED · Phase 2
-
Chronic Low Back Pain Research Project
COMPLETED · Phase 2
-
Treating Negative Affect in Low Back Pain Patients
COMPLETED · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.